- Clinical commissioning policies consultation for: Bendamustine for relapsed multiple myeloma (all ages)
- Clinical Commissioning Policy Proposition: 18F-flourodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) as part of radical radiotherapy treatment planning for oesophageal cancer (all ages)
More details here.